{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:12:59Z","timestamp":1787008379881,"version":"build-2736575974"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"22","license":[{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>After a long period of low utilization, droperidol has become easier to obtain in the US market. This comprehensive review discusses the safety, indications, clinical efficacy, and dosing of droperidol for use in the emergency department (ED) setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>In 2001 the US Food and Drug Administration (FDA) mandated a boxed warning in the labeling of droperidol after reports of QT interval prolongation associated with droperidol use. Since that time, it has been difficult to access droperidol in the United States; as a result, many practicing clinicians lack experience in its clinical use. Multiple studies have been conducted to assess the clinical efficacy and safety of droperidol use in ED patients. Results consistently show the safety of droperidol and its clinical efficacy when used as an analgesic, antiemetic, and sedative. Now that droperidol is more widely available for use in the US market, pharmacists and prescribers need to reliably translate safety and efficacy data compiled since 2001 to help ensure appropriate and effective use of the medication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Droperidol is an effective and safe option for the treatment of acute agitation, migraine, nausea, and pain for patients in the ED setting. Healthcare professionals can adopt droperidol for use in clinical practice, and they should become familiar with how to dose and monitor droperidol for safe and effective use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaa271","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T04:17:44Z","timestamp":1598329064000},"page":"1838-1845","source":"Crossref","is-referenced-by-count":18,"title":["Reintegrating droperidol into emergency medicine practice"],"prefix":"10.1093","volume":"77","author":[{"given":"Alicia","family":"Mattson","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Friend","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, St. Joseph\u2019s\/Candler, Savannah, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin S","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cabrera","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"key":"2020103004505893300_CIT0001","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jemermed.2010.07.005","article-title":"Droperidol analgesia for opioid-tolerant patients","volume":"41","author":"Richards","year":"2011","journal-title":"J Emerg Med."},{"issue":"9","key":"2020103004505893300_CIT0002","first-page":"1","article-title":"Drugs for the treatment of nausea and vomiting in adults in the emergency department setting","volume":"2015","author":"Furyk","journal-title":"Cochrane Database Syst Rev."},{"key":"2020103004505893300_CIT0003","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1060028014554445","article-title":"Droperidol for the treatment of acute migraine headaches","volume":"49","author":"Thomas","year":"2015","journal-title":"Ann Pharmacother."},{"key":"2020103004505893300_CIT0004","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/acem.13486","article-title":"Parenteral antipsychotic choice and its association with emergency department length of stay for acute agitation secondary to alcohol intoxication","volume":"26","author":"Cole","year":"2019","journal-title":"Acad Emerg Med."},{"key":"2020103004505893300_CIT0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1067\/mem.2003.110","article-title":"Droperidol, QT prolongation, and sudden death: What is the evidence?","volume":"41","author":"Kao","year":"2003","journal-title":"Ann Emerg Med."},{"key":"2020103004505893300_CIT0006","first-page":"3","article-title":"The effect of the FDA warning on the use of droperidol by U.S. emergency physicians","volume":"4","author":"Richards","year":"2003","journal-title":"Cal J Emerg Med."},{"key":"2020103004505893300_CIT0007","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2217\/pmt-2018-0070","article-title":"Considerations in addressing the opioid epidemic and chronic pain within the USA","volume":"9","author":"Marshall","year":"2019","journal-title":"Pain Manag."},{"key":"2020103004505893300_CIT0008","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4103\/0970-9185.168149","article-title":"Role of ketamine for analgesia in adults and children","volume":"32","author":"Vadivelu","year":"2016","journal-title":"J Anaesthesiol Clin Pharmacol."},{"key":"2020103004505893300_CIT0009","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet."},{"key":"2020103004505893300_CIT0010","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1213\/00000539-199411000-00028","article-title":"Droperidol causes a dose-dependent prolongation of the QT interval","volume":"79","author":"Lischke","year":"1994","journal-title":"Anesth Analg."},{"key":"2020103004505893300_CIT0011","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2146\/ajhp060505","article-title":"Evidence-based review of the black-box warning for droperidol","volume":"64","author":"Jackson","year":"2007","journal-title":"Am J Health-Syst Pharm."},{"key":"2020103004505893300_CIT0012","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/00000542-200506000-00007","article-title":"Effect of low-dose droperidol on the QT interval during and after general anesthesia: a placebo-controlled study","volume":"102","author":"White","year":"2005","journal-title":"Anesthesiology."},{"issue":"7","key":"2020103004505893300_CIT0013","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.ajem.2019.09.007","article-title":"Effectiveness and safety of droperidol in a United States emergency department","volume":"38","author":"Gaw","year":"2020","journal-title":"Am J Emerg Med."},{"key":"2020103004505893300_CIT0014","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.anes.0000281893.39781.64","article-title":"Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population","volume":"107","author":"Nuttall","year":"2007","journal-title":"Anesthesiology."},{"key":"2020103004505893300_CIT0015","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.gie.2006.01.052","article-title":"Droperidol, when used for sedation during ERCP, may prolong the QT interval","volume":"63","author":"Yimcharoen","year":"2006","journal-title":"Gastrointest Endosc."},{"key":"2020103004505893300_CIT0016","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/00000542-200506000-00006","article-title":"Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron","volume":"102","author":"Charbit","year":"2005","journal-title":"Anesthesiology."},{"key":"2020103004505893300_CIT0017","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/bcp.12527","article-title":"Small doses of droperidol do not present relevant torsadogenic actions: a double-blind, ondansetron-controlled study","volume":"79","author":"Tracz","year":"2015","journal-title":"Br J Clin Pharmacol."},{"key":"2020103004505893300_CIT0018","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.annemergmed.2015.03.016","article-title":"The safety and effectiveness of droperidol for sedation of acute behavioral disturbance in the emergency department","volume":"66","author":"Calver","year":"2015","journal-title":"Ann Emerg Med."},{"key":"2020103004505893300_CIT0019","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jemermed.2014.12.024","article-title":"American Academy of Emergency Medicine position statement: safety of droperidol use in the emergency department","volume":"49","author":"Perkins","year":"2015","journal-title":"J Emerg Med."},{"key":"2020103004505893300_CIT0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1060028014554445","article-title":"Droperidol for the treatment of acute migraine headaches","volume":"49","author":"Thomas","year":"2015","journal-title":"Ann Pharmacother."},{"key":"2020103004505893300_CIT0021","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1526-4610.1997.3706377.x","article-title":"Droperidol treatment of status migrainosus and refractory migraine","volume":"37","author":"Wang","year":"1997","journal-title":"Headache."},{"key":"2020103004505893300_CIT0022","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/01.WNL.0000042477.63516.B2","article-title":"Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial","volume":"60","author":"Silberstein","year":"2003","journal-title":"Neurology."},{"key":"2020103004505893300_CIT0023","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0735-6757(99)90096-7","article-title":"Droperidol for acute migraine headache","volume":"17","author":"Richman","year":"1999","journal-title":"Am J Emerg Med."},{"key":"2020103004505893300_CIT0024","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1553-2712.2001.tb01147.x","article-title":"Droperidol vs. prochlorperazine for benign headaches in the emergency department","volume":"8","author":"Miner","year":"2001","journal-title":"Acad Emerg Med."},{"key":"2020103004505893300_CIT0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jemermed.2003.05.005","article-title":"Droperidol vs. prochlorperazine for the treatment of acute headache","volume":"26","author":"Weaver","year":"2004","journal-title":"J Emerg Med."},{"key":"2020103004505893300_CIT0026","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1553-2712.2008.00197.x","article-title":"Olanzapine versus droperidol for the treatment of primary headache in the emergency department","volume":"15","author":"Hill","year":"2008","journal-title":"Acad Emerg Med."},{"issue":"3","key":"2020103004505893300_CIT0027","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/BF03003550","article-title":"A report on clinical uses of droperidol and fentanyl","volume":"13","author":"Mop","year":"1966","journal-title":"Can Anaes Soc J."},{"key":"2020103004505893300_CIT0028","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/BF03013155","article-title":"Comparison of tramadol and tramadol\/droperidol mixture for patient-controlled analgesia","volume":"44","author":"Jacobs Ng","year":"1997","journal-title":"Can J Anaesth."},{"key":"2020103004505893300_CIT0029","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1213\/00000539-199006000-00002","article-title":"Epidural droperidol and morphine for postoperative pain","volume":"70","author":"Naji","year":"1990","journal-title":"Anesth Analg."},{"key":"2020103004505893300_CIT0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1213\/00000539-199407000-00019","article-title":"Epidural droperidol reduces the side effects and duration of analgesia of epidural sufentanil","volume":"79","author":"Wilder-Smith","year":"1994","journal-title":"Anesth Analg."},{"key":"2020103004505893300_CIT0031","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/bja\/71.3.435","article-title":"Patient-controlled analgesia with a mixture of morphine and droperidol","volume":"71","author":"Sharma","year":"1993","journal-title":"Br J Anaesth."},{"key":"2020103004505893300_CIT0032","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jclinane.2003.03.007","article-title":"Preoperative droperidol improved postoperative pain relief in patients undergoing rotator-cuff repair during general anesthesia using intravenous morphine","volume":"15","author":"Yamamoto","year":"2003","journal-title":"J Clin Anesth."},{"key":"2020103004505893300_CIT0033","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5811\/westjem.2011.9.6868","article-title":"Psychiatric evaluation of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA Psychiatric Evaluation Workgroup","volume":"13","author":"Stowell","year":"2012","journal-title":"West J Emerg Med."},{"key":"2020103004505893300_CIT0034","first-page":"298","article-title":"Droperidol vs. haloperidol in the initial management of acutely agitated patients","volume":"45","author":"Resnick","year":"1984","journal-title":"J Clin Psychiatry."},{"issue":"4","key":"2020103004505893300_CIT0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0196-0644(05)82660-5","article-title":"Droperidol versus haloperidol for chemical restraint of agitated and combative patients","volume":"21","author":"Thomas","year":"1992","journal-title":"Ann Emerg Med."},{"key":"2020103004505893300_CIT0036","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.annemergmed.2010.05.037","article-title":"Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: The DORM study","volume":"56","author":"Isbister","year":"2010","journal-title":"Ann Emerg Med."},{"key":"2020103004505893300_CIT0037","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annemergmed.2005.07.003","article-title":"Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department","volume":"47","author":"Knott","year":"2006","journal-title":"Ann Emerg Med."},{"key":"2020103004505893300_CIT0038","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.annemergmed.2012.07.118","article-title":"Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"61","author":"Chan","year":"2013","journal-title":"Ann Emerg Med."},{"key":"2020103004505893300_CIT0039","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.annemergmed.2016.07.033","article-title":"Midazolam-droperidol, droperidol, or olanzapine for acute agitation: a randomized clinical trial","volume":"69","author":"Taylor","year":"2017","journal-title":"Ann Emerg Med."},{"issue":"12","key":"2020103004505893300_CIT0040","first-page":"CD002830","article-title":"Droperidol for psychosis-induced aggression or agitation","volume":"2016","author":"Khokhar","journal-title":"Cochrane Database Syst Rev."},{"issue":"16","key":"2020103004505893300_CIT0041","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2165\/00003495-200666160-00009","article-title":"Intravenous droperidol a review of its use in the management of postoperative nausea and vomiting","volume":"66","author":"Mckeage","year":"2006","journal-title":"Drugs."},{"key":"2020103004505893300_CIT0042","first-page":"1256","article-title":"Small-dose droperidol effectively reduces nausea in a general surgical adult patient population","volume":"91","author":"Kreisler","year":"2000","journal-title":"Anesth Analg."},{"key":"2020103004505893300_CIT0043","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jopan.2015.08.009","article-title":"SAMBA consensus guidelines for the management of postoperative nausea and vomiting: an executive summary for perianesthesia nurses","volume":"30","author":"Hooper","year":"2015","journal-title":"J Perianesthesia Nurs."},{"key":"2020103004505893300_CIT0044","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajem.2005.08.017","article-title":"Antiemetics in the ED: a randomized controlled trial comparing 3 common agents","volume":"24","author":"Braude","year":"2006","journal-title":"Am J Emerg Med."},{"key":"2020103004505893300_CIT0045","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/acem.13650","article-title":"Randomized placebo-controlled trial of droperidol and ondansetron for adult emergency department patients with nausea","volume":"26","author":"Meek","year":"2019","journal-title":"Acad Emerg Med."},{"key":"2020103004505893300_CIT0046","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/15563650.2018.1564324","article-title":"The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome","volume":"57","author":"Lee","year":"2019","journal-title":"Clin Toxicol."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/77\/22\/1838\/34055758\/zxaa271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/77\/22\/1838\/34055758\/zxaa271.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T03:45:11Z","timestamp":1696563911000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/77\/22\/1838\/5896765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":46,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2020,8,25]]},"published-print":{"date-parts":[[2020,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaa271","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11,15]]},"published":{"date-parts":[[2020,8,25]]}}}